Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review

  • ID: 1290780
  • SWOT Analysis
  • 58 pages
  • GlobalData
  • Meridian Bioscience Inc
1 of 5

FEATURED COMPANIES

  • Alere Inc
  • Becton Dickinson and Co
  • Cepheid
  • Nanosphere Inc
  • Quidel Corp
  • Scivanta Medical Corp
  • MORE
Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. The company develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. Meridian offers its products to acute care hospitals, outpatient clinics, reference laboratories and physician office laboratories in several countries worldwide. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Cincinnati, Ohio, the US.

Meridian Bioscience Inc Key Recent Developments

Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of $52.3 Million In Q1 fiscal 2018
Nov 09, 2017: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics
Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance
Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alere Inc
  • Becton Dickinson and Co
  • Cepheid
  • Nanosphere Inc
  • Quidel Corp
  • Scivanta Medical Corp
  • MORE
Section 1 - About the Company
  • Meridian Bioscience Inc - Key Facts
  • Meridian Bioscience Inc - Key Employees
  • Meridian Bioscience Inc - Key Employee Biographies
  • Meridian Bioscience Inc - Major Products and Services
  • Meridian Bioscience Inc - History
  • Meridian Bioscience Inc - Company Statement
  • Meridian Bioscience Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Meridian Bioscience Inc - Business Description
  • Meridian Bioscience Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Meridian Bioscience Inc - Strengths
  • Meridian Bioscience Inc - Weaknesses
  • Meridian Bioscience Inc - Opportunities
  • Meridian Bioscience Inc - Threats
  • Meridian Bioscience Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Meridian Bioscience Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 25, 2018: Meridian Bioscience Reports Net Revenue Of $52.3 Million In Q1 fiscal 2018
  • Nov 09, 2017: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance
  • Oct 23, 2017: FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues
  • Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics
  • Oct 19, 2017: Meridian Bioscience Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings Guidance
  • Oct 10, 2017: Meridian Bioscience Appoints Jack Kenny as Chief Executive Officer
  • Aug 08, 2017: Meridian Bioscience Elects John Rice to the Board of Directors
  • Aug 02, 2017: Bioline Launches New JetSeq Clean Kit for Next-Generation Sequencing
  • Jul 27, 2017: Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results
  • Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Meridian Bioscience Inc, Key Facts
  • Meridian Bioscience Inc, Key Employees
  • Meridian Bioscience Inc, Key Employee Biographies
  • Meridian Bioscience Inc, Major Products and Services
  • Meridian Bioscience Inc, History
  • Meridian Bioscience Inc, Other Locations
  • Meridian Bioscience Inc, Subsidiaries
  • Meridian Bioscience Inc, Key Competitors
  • Meridian Bioscience Inc, Ratios based on current share price
  • Meridian Bioscience Inc, Annual Ratios
  • Meridian Bioscience Inc, Annual Ratios
  • Meridian Bioscience Inc, Annual Ratios
  • Meridian Bioscience Inc, Interim Ratios
  • Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Meridian Bioscience Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Meridian Bioscience Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Meridian Bioscience Inc, Performance Chart (2013 - 2017)
  • Meridian Bioscience Inc, Ratio Charts
  • Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Scivanta Medical Corp
  • Quidel Corp
  • Nanosphere Inc
  • Cepheid
  • Becton Dickinson and Co
  • Alere Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll